← Evidence map

ReviewBiotechnology and bioengineering2021

Efficacy of mesenchymal stromal cells and cellular products in improvement of symptoms for COVID-19 and similar lung diseases.

Behnaz Banimohamad-Shotorbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33629351